FDA Determines Regulatory Review Period for Arctic Front Cryocatheter System Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the Arctic Front Cryocatheter System, a medical device, in accordance with patent extension laws, following a submission to the Director of Patents and Trademarks at the US Department of Commerce.